Free Trial

Greenwich LifeSciences (GLSI) Short Interest Ratio & Short Volume

$13.17
-0.02 (-0.15%)
(As of 05/29/2024 ET)

Greenwich LifeSciences Short Interest Data

Current Short Interest
177,100 shares
Previous Short Interest
189,100 shares
Change Vs. Previous Month
-6.35%
Dollar Volume Sold Short
$2.61 million
Short Interest Ratio
4.1 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
12,880,000 shares
Float Size
5,850,000 shares
Short Percent of Float
3.03%
Today's Trading Volume
17,097 shares
Average Trading Volume
41,355 shares
Today's Volume Vs. Average
41%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Greenwich LifeSciences ?

Sign up to receive the latest short interest report for Greenwich LifeSciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GLSI Short Interest Over Time

GLSI Days to Cover Over Time

GLSI Percentage of Float Shorted Over Time

Greenwich LifeSciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024177,100 shares $2.61 million -6.4%3.0%4.1 $14.75
4/30/2024189,100 shares $2.35 million +2.2%3.2%3.6 $12.42
4/15/2024185,100 shares $2.64 million +31.7%3.2%3.6 $14.26
3/31/2024140,500 shares $2.80 million +2.5%2.4%2.9 $19.94
3/15/2024137,100 shares $2.40 million +13.0%2.4%3 $17.50
2/29/2024121,300 shares $1.48 million -30.1%2.1%3.2 $12.16
2/15/2024173,600 shares $2.01 million +12.4%3.0%5.5 $11.60
1/31/2024154,500 shares $1.33 million -4.2%2.6%8.1 $8.64
1/15/2024161,200 shares $1.49 million +5.8%2.8%9.2 $9.26
12/31/2023152,300 shares $1.60 million +32.8%2.6%9.5 $10.52
12/15/2023114,700 shares $1.23 million -31.3%2.0%7.9 $10.76
11/30/2023167,000 shares $1.95 million +0.1%2.9%11.6 $11.70
11/15/2023166,800 shares $1.83 million +2.0%2.9%12.4 $10.98
10/31/2023163,500 shares $1.37 million -11.3%2.8%12.7 $8.36
10/15/2023184,300 shares $1.59 million -5.5%3.1%13.8 $8.64
9/30/2023195,100 shares $1.72 million +0.1%3.3%14.2 $8.84
9/15/2023194,900 shares $1.76 million +7.9%3.3%12.8 $9.04
8/31/2023180,700 shares $1.66 million -3.4%3.1%10.2 $9.17
8/15/2023187,000 shares $1.99 million +5.2%3.2%9.4 $10.66
7/31/2023177,800 shares $1.64 million -4.6%3.0%8.6 $9.20
7/15/2023186,300 shares $1.74 million -4.7%3.2%7.8 $9.34
6/30/2023195,500 shares $1.89 million -12.7%3.3%5.2 $9.65
6/15/2023224,000 shares $2.47 million -1.0%3.8%5.5 $11.04
5/31/2023226,200 shares $2.46 million -6.5%6.3%5.5 $10.89
5/15/2023242,000 shares $2.72 million -21.7%6.8%5.6 $11.25
4/30/2023308,900 shares $3.31 million -9.2%8.6%6.7 $10.71
4/15/2023340,000 shares $4.02 million +23.3%9.5%6.9 $11.81
3/31/2023275,700 shares $3.80 million +43.2%7.7%6.3 $13.79
3/15/2023192,500 shares $2.49 million +9.9%5.4%4.7 $12.92
2/28/2023175,100 shares $2.73 million -1.1%4.9%4.4 $15.61
2/15/2023177,100 shares $2.98 million -2.2%4.9%4.1 $16.85
1/31/2023181,100 shares $3.59 million -9.8%5.0%4 $19.84
1/15/2023200,800 shares $3.27 million -10.6%5.6%4.5 $16.26
12/30/2022224,600 shares $3.41 million +15.6%6.2%5.3 $15.20
12/15/2022194,300 shares $2.52 million -17.8%5.4%5 $12.97
11/30/2022236,400 shares $3.30 million +0.2%6.6%5.5 $13.95
11/15/2022235,900 shares $2.61 million +26.5%6.6%5.8 $11.08
10/31/2022186,500 shares $1.68 million -21.6%5.2%4.4 $9.01
10/15/2022238,000 shares $2.35 million -10.6%6.6%4.9 $9.86
9/30/2022266,200 shares $2.42 million +3.5%24.0%1.2 $9.10
Gold Set to EXPLODE! (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
9/15/2022257,100 shares $2.66 million +10.6%23.2%1.1 $10.35
8/31/2022232,400 shares $2.20 million +19.5%18.3%0.9 $9.48
8/15/2022194,500 shares $2.02 million -34.6%15.1%0.6 $10.39
7/31/2022297,200 shares $2.40 million -29.0%23.0%1 $8.09
7/15/2022418,400 shares $3.87 million +59.8%32.4%1.3 $9.24
6/30/2022261,800 shares $2.22 million -28.7%20.3%1.8 $8.47
6/15/2022367,000 shares $2.98 million +5.6%10.1%2.8 $8.12
5/31/2022347,500 shares $2.69 million +12.7%11.3%3.2 $7.74
5/15/2022308,400 shares $2.99 million +3.4%10.1%4.4 $9.69
4/30/2022298,300 shares $3.53 million +8.9%9.7%4.4 $11.85
4/15/2022273,900 shares $4.70 million -14.3%3.1%4 $17.16
3/31/2022319,500 shares $6.27 million +59.8%3.6%4.9 $19.62
3/15/2022200,000 shares $4.27 million +7.2%2.2%2.6 $21.33
2/28/2022186,500 shares $3.63 million +1.3%2.0%2.5 $19.49
2/15/2022184,200 shares $3.55 million +25.7%2.0%2.6 $19.26
1/31/2022146,500 shares $2.71 million +67.2%1.6%2.5 $18.47
1/15/202287,600 shares $1.77 million -18.4%N/A1.7 $20.24
12/31/2021107,300 shares $2.61 million -2.7%1.2%2.4 $24.33
12/15/2021110,300 shares $2.91 million +3.6%1.1%2.8 $26.36
11/30/2021106,500 shares $3.35 million +24.9%3.9%3.2 $31.43
11/15/202185,300 shares $2.99 million -21.2%3.1%2.3 $35.11
10/29/2021108,300 shares $3.83 million -7.1%4.0%3 $35.36
10/15/2021116,600 shares $4.43 million -49.4%4.4%3 $37.96
9/30/2021230,300 shares $9.00 million +72.3%9.2%5.4 $39.07
9/15/2021133,700 shares $5.59 million -11.0%5.3%2 $41.82
8/31/2021150,300 shares $6.02 million -18.1%6.0%1.9 $40.02
8/13/2021183,500 shares $7.43 million -10.5%7.5%1.8 $40.50
7/30/2021205,100 shares $8.10 million +3.1%8.4%1.9 $39.47
7/15/2021199,000 shares $8.34 million +2.4%8.2%1.6 $41.92
6/30/2021194,400 shares $8.74 million +63.5%8.0%1 $44.94
6/15/2021118,900 shares $4.72 million -12.6%4.9%0.3 $39.73
5/28/2021136,000 shares $5.04 million -4.2%5.6%0.3 $37.08
5/14/2021142,000 shares $4.51 million +15.5%5.9%0.2 $31.78
4/30/2021122,900 shares $4.69 million -61.3%5.2%0.2 $38.17
4/15/2021317,500 shares $11.23 million +65.5%13.3%0.5 $35.36
3/31/2021191,900 shares $6.31 million -21.3%11.4%0.3 $32.90
3/15/2021243,900 shares $7.10 million +218.8%14.4%0.5 $29.12
2/26/202176,500 shares $2.50 million +58.4%4.8%0.1 $32.63
2/12/202148,300 shares $1.93 million +20.5%3.1%0.1 $39.98
1/29/202140,100 shares $1.37 million -20.9%2.5%0 $34.20
1/15/202150,700 shares $1.82 million No Change3.2%0.1 $35.90

GLSI Short Interest - Frequently Asked Questions

What is Greenwich LifeSciences' current short interest?

Short interest is the volume of Greenwich LifeSciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 177,100 shares of GLSI short. 3.03% of Greenwich LifeSciences' shares are currently sold short. Learn More on Greenwich LifeSciences' current short interest.

What is a good short interest ratio for Greenwich LifeSciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLSI shares currently have a short interest ratio of 4.0. Learn More on Greenwich LifeSciences's short interest ratio.

What is a good short interest percentage for Greenwich LifeSciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.03% of Greenwich LifeSciences' floating shares are currently sold short.

Is Greenwich LifeSciences' short interest increasing or decreasing?

Greenwich LifeSciences saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 177,100 shares, a decline of 6.3% from the previous total of 189,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Greenwich LifeSciences' float size?

Greenwich LifeSciences currently has issued a total of 12,880,000 shares. Some of Greenwich LifeSciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Greenwich LifeSciences currently has a public float of 5,850,000 shares.

How does Greenwich LifeSciences' short interest compare to its competitors?

3.03% of Greenwich LifeSciences' shares are currently sold short. Here is how the short interest of companies compare to Greenwich LifeSciences: Puma Biotechnology, Inc. (8.63%), ALX Oncology Holdings Inc. (11.56%), Calliditas Therapeutics AB (publ) (0.03%), Dianthus Therapeutics, Inc. (10.17%), Silence Therapeutics plc (1.94%), AnaptysBio, Inc. (18.36%), Harrow, Inc. (14.08%), Pharming Group (0.01%), Arbutus Biopharma Co. (2.83%), Phathom Pharmaceuticals, Inc. (43.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Greenwich LifeSciences stock?

Short selling GLSI is an investing strategy that aims to generate trading profit from Greenwich LifeSciences as its price is falling. GLSI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Greenwich LifeSciences?

A short squeeze for Greenwich LifeSciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLSI, which in turn drives the price of the stock up even further.

How often is Greenwich LifeSciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLSI, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GLSI) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners